Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Takeda
Biotech
Takeda strikes Innovent pact worth up to $11.4B
The deal, which includes $10.2 billion in milestones, puts the biologics at the center of Takeda’s efforts to establish new growth drivers.
Nick Paul Taylor
Oct 22, 2025 9:15am
BioCryst inks $700M Astria deal to rival Takeda in rare disease
Oct 14, 2025 10:30am
Takeda turns to AI drug designer after whittling down R&D focus
Oct 14, 2025 5:00am
Takeda lays off 137 US staff as part of cell therapy retreat
Oct 1, 2025 3:13pm
BMS, Takeda join peers in push to improve AI by pooling data
Oct 1, 2025 10:34am
Japan biotech inks RNA research pact that includes mRNA compounds
Sep 19, 2025 10:49am